Results 171 to 180 of about 22,958 (212)
Some of the next articles are maybe not open access.
Archives of Internal Medicine, 1963
Recently there has been increasing recognition of hemorrhagic thrombocythemia as a clinical entity, although its status as a distinct pathological disorder is questioned. 1,2 Synonyms are essential thrombocytosis, essential thrombophilia, thrombocythemia hemorrhagica, and hyperthrombotic myelosis.
A T, WEBB, F L, MEYER, E R, LONSER
openaire +2 more sources
Recently there has been increasing recognition of hemorrhagic thrombocythemia as a clinical entity, although its status as a distinct pathological disorder is questioned. 1,2 Synonyms are essential thrombocytosis, essential thrombophilia, thrombocythemia hemorrhagica, and hyperthrombotic myelosis.
A T, WEBB, F L, MEYER, E R, LONSER
openaire +2 more sources
JAMA, 1965
EVEN BEFORE Nygaard's and Brown's inclusion of a patient with thrombocytosis in their series of five patients with "essential thrombophilia" in 1937, 1 scattered reports of patients with thrombohemorrhagic phenomena and increased numbers of circulating platelets had appeared in the English and foreign medical literature under such names as piastrinemia,
openaire +2 more sources
EVEN BEFORE Nygaard's and Brown's inclusion of a patient with thrombocytosis in their series of five patients with "essential thrombophilia" in 1937, 1 scattered reports of patients with thrombohemorrhagic phenomena and increased numbers of circulating platelets had appeared in the English and foreign medical literature under such names as piastrinemia,
openaire +2 more sources
Essential thrombocythemia and pregnancy
European Journal of Obstetrics & Gynecology and Reproductive Biology, 2011Essential thrombocythaemia (ET) is an acquired myeloproliferative neoplasm, characterised by persistent thrombocytosis and a tendency for either thrombosis or haemorrhage. Among myeloproliferative neoplasms, ET is the most prevalent in young women, which constitute a special group due to their childbearing potential.
Valera, Marie-Cécile +4 more
openaire +3 more sources
Thrombocythemia as a Cause of Erythermalgia
Archives of Dermatology, 1977Erythermalgia is a distinctive clinical entity characterized by local redness, warmth, and burning pain in the distal portions of the extremities. In this study, erythemalgia was observed in two patients with myeloproliferative disease. A new theory suggesting abnormally rapid platelet aggregation as a cause of erythermalgia was advanced. The following
openaire +2 more sources
Familial essential thrombocythemia
The American Journal of Medicine, 1986Primary or essential thrombocythemia is rarely observed in childhood, and familial occurrence has been reported only once. In this study, essential thrombocythemia is documented in five members of both sexes from two to 62 years of age in three successive generations.
M E, Eyster +6 more
openaire +2 more sources
Essential Thrombocythemia in an Infant
Journal of Pediatric Hematology/Oncology, 1996To report the unusual occurrence of essential thrombocythemia (ET) in a 5-month-old infant.The child was referred by her pediatrician for a high platelet count detected on routine blood testing. The child was asymptomatic except for failure to thrive. Diagnostic tests to rule out secondary causes of thrombocytosis as well as myeloproliferative syndrome
G, Kapoor, H, Correa, L C, Yu
openaire +2 more sources
Primary or Hemorrhagic Thrombocythemia
Archives of Internal Medicine, 1968Fifteen patients with primary thrombocythemia were seen at the Mayo Clinic from 1960 through 1966. Nine patients presented with hemorrhagic manifestations, especially gastrointestinal bleeding. Three patients presented with thrombotic phenomena, including one patient with the nephrotic syndrome. Platelet counts in excess of 1 million/cu mm were seen in
openaire +2 more sources
Thrombocythemia and Neurologic Effects
Annals of Internal Medicine, 1984Excerpt To the editor: Jabaily and colleagues have (1) attributed neurologic manifestations in patients with essential thrombocythemia to elevated platelet levels.
openaire +2 more sources
Management of Essential Thrombocythemia
Hematology, 2011Abstract Essential thrombocythemia (ET) is a Philadelphia chromosome (Ph)–negative myeloproliferative neoplasm (MPN) characterized by thrombocytosis and megakaryocytic hyperplasia of the bone marrow, with presence of the JAK2 V617F mutation in 50%-60% of patients. ET evolves to myelofibrosis in a minority of cases, whereas transformation
openaire +2 more sources